// App-Quantinova.ai

12021 : Anti-factor Xa Activity Value At Peak And Trough Times In High Risk Patients With Venous Thromboembolism On Apixaban Therapy

Researchers

Presenter

  • Ryohei Ono

Principal Investigators

  • Kenichi Fukushima

  • Tatsuro Yamazaki

  • Hidehisa Takahashi

  • Yasuhiko Hori

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • apixaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved